Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

New York, Jan 13, 2026, 12:12 EST — Regular session Johnson & Johnson shares climbed roughly 1.6% to $212.98 on Tuesday, bucking a minor slide in healthcare stocks as the overall market showed little direction. The stock hit a session peak of $213.48 and dipped to $208.93 at its low. Meanwhile, the Health Care Select Sector SPDR ETF fell around 0.3%, with the S&P 500 ETF holding steady. Investors are trying to distinguish one-off legal noise from factors that could impact cash costs and guidance in the coming quarters. For Johnson & Johnson, court rulings and drug-data updates often overlap
KEPCO stock jumps 9% after broker lifts target to 70,000 won — what to watch next for 015760

KEPCO stock jumps 9% after broker lifts target to 70,000 won — what to watch next for 015760

Seoul, Jan 14, 2026, 02:00 KST — Market closed. Korea Electric Power Corp (015760.KS) shares surged 9.2% on Tuesday, closing at 55,700 won—their best finish in a year—after reaching an intraday peak of 55,800 won. The state-run utility’s stock was at 51,000 won just the day before. (google.com) The move came after renewed bullish forecasts from brokers. NH Investment & Securities bumped its target price up to 70,000 won from 60,000, maintaining a “buy” rating. Analyst Lee Min-jae noted that KEPCO is now in a stage where both earnings and its financial strength could improve simultaneously, boosting its valuation support.
CoreWeave stock slips today after CEO swats away Nvidia “circular financing” claims

CoreWeave stock slips today after CEO swats away Nvidia “circular financing” claims

New York, January 13, 2026, 11:02 ET — Regular session CoreWeave (CRWV) shares slipped 1.4% to $88.67 on Tuesday, pulling back after nearly a 12% surge the day before. The jump came after management reassured investors about the lifespan of its graphics chips powering AI data centers. (The Motley Fool) The market is wrestling with a straightforward question tangled in complexity: how long will pricey AI hardware hold its value, and what’s the ongoing cost to keep upgrading it? CoreWeave is caught in the middle. Its model hinges on funding vast quantities of chips and maintaining high rental utilization. Investors,
Capital One (COF) stock steadies after Trump’s 10% card-rate cap threat as $425 million settlement hits

Capital One (COF) stock steadies after Trump’s 10% card-rate cap threat as $425 million settlement hits

New York, January 13, 2026, 11:03 AM EST — Regular session Shares of Capital One Financial Corp ticked up Tuesday, clawing back a bit after Monday’s dip. Investors are wrestling with how aggressive Washington might get on capping credit-card interest rates—and what that could spell for lenders reliant on card business. By late morning, the stock was trading around $233.84, up roughly 0.3%. Policy risk is in focus. U.S. President Donald Trump has proposed a 10% cap on credit-card interest rates for one year starting Jan. 20, but hasn’t specified how it would be enforced. This rattled lenders and card
Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

New York, January 13, 2026, 11:31 EST — Regular session Moderna shares were up $3.97, or 11.7%, at $37.81 by late morning in New York, lifting the vaccine maker to one of the stronger movers in biotech trading. The bounce comes as investors try to pin down what “post-pandemic Moderna” looks like — smaller, more volatile, and still dependent on seasonal vaccine demand that can shift fast. The company’s early look at 2025 is being read as a test of whether the slide has finally slowed. Moderna said it expects about $1.9 billion in 2025 sales, near the top end
Bank of America stock slips as Trump credit-card cap clouds BAC earnings

Bank of America stock slips as Trump credit-card cap clouds BAC earnings

New York, Jan 13, 2026, 11:55 AM EST — Regular session Shares of Bank of America Corp (BAC) dropped 0.9% to $54.72 in late-morning trading Tuesday in New York, as investors weighed a proposed cap on credit-card interest rates. The stock reacted after U.S. consumer prices rose 0.3% in December, matching expectations, with a 2.7% increase year-on-year. Core CPI, excluding food and energy, climbed 0.2% monthly and 2.6% annually. The Fed is widely expected to hold its policy rate steady at the Jan. 27-28 meeting, the report said. “The recent run of figures suggests inflation has peaked,” said Michael Pearce,
Strategy (MSTR) stock jumps as $1.25 billion Bitcoin buy and insider purchase hit the tape

Strategy (MSTR) stock jumps as $1.25 billion Bitcoin buy and insider purchase hit the tape

New York, January 13, 2026, 11:37 EST — Regular session Shares of Strategy Inc climbed roughly 3.6% to $168.01 Tuesday morning, buoyed by a 1.6% rise in bitcoin following the company’s announcement of a $1.25 billion crypto purchase. The firm sold about 6.83 million shares and 1.19 million preferred STRC shares, netting approximately $1.25 billion. It deployed those funds to acquire 13,627 bitcoin, paying an average of $91,519 per coin, boosting its total holdings to 687,410. (SEC) This filing is crucial since Strategy’s stock still acts as a bitcoin proxy, but with a twist: it keeps tapping the equity market
IREN Limited stock nudges higher after H.C. Wainwright upgrade as bitcoin firms

IREN Limited stock nudges higher after H.C. Wainwright upgrade as bitcoin firms

New York, Jan 13, 2026, 11:36 ET — Regular session IREN Limited shares ticked up roughly 1% to $50.82 around midday Tuesday. The boost came after H.C. Wainwright raised its rating on the Nasdaq-listed firm to “buy,” attaching an $80 price target. (MarketBeat) Bitcoin climbed roughly 1.5% to $93,434, while mining-related stocks like Marathon Digital, Riot Platforms, and CleanSpark also saw gains. The upgrade is significant since IREN now stands as a high-beta play linked to two volatile arenas: crypto prices and the race for AI computing power. When risk appetite changes, the stock can swing sharply. Investors are also
Eli Lilly stock (LLY) edges up as FDA clears GLP-1 label cloud; $150 pill launch looms

Eli Lilly stock (LLY) edges up as FDA clears GLP-1 label cloud; $150 pill launch looms

New York, Jan 13, 2026, 11:51 EST — Regular session Shares of Eli Lilly and Company inched up 0.2% to $1,083.63 on Tuesday, fluctuating between $1,070 and $1,090 as roughly 736,000 shares exchanged hands. The move followed the U.S. Food and Drug Administration’s request that drugmakers strip suicide-related warnings from labels on GLP-1 weight-loss medications, including Lilly’s Zepbound and Novo Nordisk’s Wegovy. (Reuters) The request matters because safety language on labels can influence how quickly doctors prescribe and how confident insurers feel about coverage. In a market already clogged with supply and demand chatter, even minor shifts in perceived risk
TTM Technologies stock surges nearly 20% as TTMI draws fresh attention at Needham Growth Conference

TTM Technologies stock surges nearly 20% as TTMI draws fresh attention at Needham Growth Conference

New York, Jan 13, 2026, 11:23 EST — Regular session underway TTM Technologies shares surged roughly 19% Tuesday, hitting $92.84 late morning. The circuit-board manufacturer pushed higher on strong volume, continuing its recent rally. Investors zeroed in on TTM’s upcoming slot at the Needham Growth Conference in New York. CEO Edwin Roks and CFO Dan Boehle were set to speak early Tuesday. (TTM Technologies, Inc.) This year’s Needham event spans several days, combining virtual and in-person sessions and attracting hundreds of companies. This format tends to funnel quick capital into high-momentum stocks. (Needham & Company) TTM is often described as
AppLovin stock rises as Wall Street resets targets — what traders are watching next

AppLovin stock rises as Wall Street resets targets — what traders are watching next

New York, January 13, 2026, 11:12 AM (ET) — Market open AppLovin shares rose roughly 0.5% Tuesday, recovering after a volatile start as investors digested new price targets from brokers on the ad-tech firm. Timing is crucial. Since the start of the year, AppLovin has behaved like a momentum play, and even slight shifts in sell-side sentiment can sway the stock when positioning is tight and expectations run high. At 11:12 a.m. ET, the stock changed hands at $662.24, having fluctuated from a low of $643.00 to a high of $666.57. The wider market edged lower, with the S&P 500
UiPath stock slides after CEO Daniel Dines sells shares — what PATH investors watch next

UiPath stock slides after CEO Daniel Dines sells shares — what PATH investors watch next

New York, Jan 13, 2026, 11:14 EST — Regular session Shares of UiPath Inc dropped roughly 7.7% to $15.92 on Tuesday following a regulatory filing that revealed new insider selling at the automation software company. The stock had climbed to $17.63 earlier in the day. This shift is crucial as UiPath returns to the spotlight while investors assess enterprise spending on automation and AI. With the fiscal quarter closing, traders latch onto any sign of subscription growth—or its absence. Insider sales happen regularly, but they tend to draw notice when a stock is volatile and lacks an earnings report to

Stock Market Today

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Amazon stock slides as $200B AI spending plan meets cautious profit outlook

Amazon stock slides as $200B AI spending plan meets cautious profit outlook

7 February 2026
Amazon shares fell 9% Friday after the company announced plans for $200 billion in 2026 capital spending, mainly for AWS and AI, and issued a first-quarter profit outlook below estimates. The stock drop could erase $200 billion in market value. Fourth-quarter net sales rose 14% to $213.4 billion, while free cash flow declined due to higher spending on AI infrastructure.
Go toTop